Bluebird

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said late on Friday. "SKYSONA is the ...

September 18, 2022BY Reuters
Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval

The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare ...

August 19, 2022BY Reuters
Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise

What’s that flash of bright blue in the trees? If you’re out camping or hiking in the mountains ...

September 23, 2020BY Epoch Inspired Staff
American Express and Wal-Mart’s Bluebird Venture

The American Express Co. and Wal-Mart Stores Inc. Bluebird program was made official on Oct. 8.

November 1, 2012BY Heide B. Malhotra